Masato Furuhashi Selected Research

Fatty Acid-Binding Proteins

8/2022	Fatty acid metabolism is involved in both retinal physiology and the pathology of retinal vascular diseases.
3/2022	Fatty Acid-Binding Proteins 4 and 5 Are Involved in the Pathogenesis of Retinal Vascular Diseases in Different Manners.
11/2021	Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy.
1/2021	Fatty acid-binding protein 4 is an independent factor in the pathogenesis of retinal vein occlusion.
1/2021	Elevated circulating FABP4 concentration predicts cardiovascular death in a general population: a 12-year prospective study.
11/2020	Significance of urinary fatty acid-binding protein 4 level as a possible biomarker for the identification of minimal change disease in patents with nephrotic-range proteinuria.
1/2020	Treatment with anagliptin, a DPP-4 inhibitor, decreases FABP4 concentration in patients with type 2 diabetes mellitus at a high risk for cardiovascular disease who are receiving statin therapy.
3/2019	Fatty Acid-Binding Protein 4 in Cardiovascular and Metabolic Diseases.
1/2018	Circulating Fatty Acid-Binding Protein 4 Concentration Predicts the Progression of Carotid Atherosclerosis in a General Population Without Medication.
9/2017	Ectopic Fatty Acid-Binding Protein 4 Expression in the Vascular Endothelium is Involved in Neointima Formation After Vascular Injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Masato Furuhashi Research Topics

Disease

32	Insulin Resistance 05/2022 - 02/2003
21	Obesity 09/2022 - 10/2003
14	Atherosclerosis 05/2022 - 05/2003
10	Dyslipidemias (Dyslipidemia) 09/2022 - 01/2016
10	Hypertension (High Blood Pressure) 05/2022 - 09/2003
10	Type 2 Diabetes Mellitus (MODY) 01/2022 - 09/2004
9	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 02/2003
8	Fatty Liver 09/2022 - 08/2006
6	Liver Diseases (Liver Disease) 09/2022 - 11/2018
6	Non-alcoholic Fatty Liver Disease 09/2022 - 01/2021
6	Hyperuricemia 01/2022 - 09/2019
6	Inflammation (Inflammations) 03/2019 - 05/2007
4	Diabetes Mellitus 05/2022 - 03/2019
4	Proteinuria 01/2022 - 01/2014
4	Essential Hypertension 02/2005 - 07/2003
3	Diabetic Retinopathy (Retinopathy, Diabetic) 08/2022 - 11/2021
3	Retinal Vein Occlusion 08/2022 - 01/2021
3	Hypoxia (Hypoxemia) 05/2022 - 05/2014
3	Coronary Artery Disease (Coronary Atherosclerosis) 04/2022 - 01/2016
3	Metabolic Diseases (Metabolic Disease) 11/2020 - 06/2008
2	Vascular Diseases (Vascular Disease) 08/2022 - 03/2022
2	Platelet Glycoprotein IV Deficiency 04/2022 - 02/2003
2	Epiretinal Membrane (Epiretinal Membranes) 03/2022 - 01/2021
2	Hypercholesterolemia 01/2022 - 01/2016
2	Fibrosis (Cirrhosis) 01/2021 - 01/2011
2	Body Weight (Weight, Body) 09/2019 - 10/2004
2	Acute Kidney Injury (Acute Renal Failure) 11/2018 - 10/2005
2	Carotid Artery Diseases 01/2018 - 01/2017
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 06/2007
2	Hyperinsulinism (Hyperinsulinemia) 09/2003 - 05/2003
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 08/2022
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 04/2022
1	Hypoalbuminemia 01/2022
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 12/2021
1	Graves Ophthalmopathy 11/2021

Drug/Important Bio-Agent (IBA)

28	Fatty Acid-Binding ProteinsIBA 08/2022 - 02/2005
17	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2003
11	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2011
9	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2003
9	Uric Acid (Urate)IBA 05/2022 - 01/2018
9	Insulin (Novolin)FDA Link 03/2022 - 02/2003
9	AdipokinesIBA 01/2021 - 04/2015
8	Triglycerides (Triacylglycerol)IBA 09/2022 - 02/2003
8	LipidsIBA 03/2019 - 02/2003
7	AdiponectinIBA 05/2022 - 07/2003
5	Fatty Acids (Saturated Fatty Acids)IBA 08/2022 - 02/2003
5	HDL CholesterolIBA 05/2022 - 02/2003
4	Sitagliptin Phosphate (Januvia)FDA Link 01/2022 - 12/2015
3	TransferasesIBA 08/2022 - 12/2021
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2022 - 11/2021
3	CholesterolIBA 03/2022 - 01/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2020
3	anagliptinIBA 01/2022 - 01/2020
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2022 - 12/2015
3	Alanine Transaminase (SGPT)IBA 12/2021 - 01/2018
3	Xanthine DehydrogenaseIBA 09/2021 - 09/2019
3	CytokinesIBA 01/2021 - 01/2011
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 09/2022 - 09/2019
2	Retinaldehyde (Retinal)IBA 08/2022 - 03/2022
2	Messenger RNA (mRNA)IBA 05/2022 - 10/2021
2	LDL CholesterolIBA 04/2022 - 01/2020
2	oxidized low density lipoproteinIBA 04/2022 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 04/2022 - 11/2020
2	fibroblast growth factor 21IBA 03/2022 - 07/2019
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2016
2	LDL Receptors (LDL Receptor)IBA 01/2022 - 01/2016
2	Proprotein Convertase 9IBA 01/2022 - 01/2016
2	Warfarin (Coumadin)FDA LinkGeneric 03/2021 - 01/2017
2	HypoxanthineIBA 11/2020 - 07/2020
2	XanthineIBA 11/2020 - 07/2020
2	Pharmaceutical PreparationsIBA 01/2020 - 06/2008
2	Hemoglobins (Hemoglobin)IBA 01/2020 - 01/2018
2	EnzymesIBA 09/2019 - 01/2018
2	Phosphotransferases (Kinase)IBA 02/2014 - 09/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012 - 01/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2012 - 05/2003
2	FructoseIBA 10/2004 - 02/2003
1	IronIBA 09/2022
1	Urea (Carbamide)FDA LinkGeneric 09/2022
1	NitrogenIBA 09/2022
1	CD36 AntigensIBA 04/2022
1	AcidsIBA 04/2022
1	GlycolipidsIBA 03/2022
1	Enalapril FDA LinkGeneric 01/2022
1	Methimazole (Thiamazole)FDA LinkGeneric 01/2022
1	25-hydroxyvitamin DIBA 12/2021
1	AlbuminsIBA 12/2021
1	1,25-dihydroxyvitamin DIBA 12/2021
1	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2021
1	hydroxide ionIBA 12/2021
1	ProstaglandinsIBA 11/2021
1	C-Reactive ProteinIBA 11/2021
1	CreatinineIBA 11/2021
1	Tissue Inhibitor of MetalloproteinasesIBA 10/2021
1	Fibronectins (Fibronectin)IBA 10/2021

Therapy/Procedure

4	Renal Dialysis (Hemodialysis) 12/2021 - 01/2011
3	Therapeutics 01/2022 - 01/2020
2	Vitrectomy 03/2022 - 01/2021
2	Kidney Transplantation 03/2021 - 01/2017
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2008 - 07/2008